Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

China Takayasu Arteritis Registry (CTA Registry)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Takayasu arteritis (TA) is a chronic large-vessel vasculitis that mainly affects the aorta and its major branches. The epidemiology and pathophysiology of TA is still unclear in China, although many studies have been done. Our previous study supporting by National Natural Science Foundation of China indicated the cytokines such as hs-CRP, NT-proBNP and tumor necrosis factor-alpha (TNF-α) can be used to monitor TA activity, and HLA gene alleles were associated with TA in Chinese han population. Further investigations with larger samples are needed to fully understand the a pathophysiology of TA. The purpose of this study is to build a Chinese national registry system for TA to obtain real-world information, such as current status of characteristics, diagnosis, disease activity, the severity of disease, treatment and outcomes of Chinese TA patients. To analysis and development of effective disease monitoring and treatment strategies.

Who May Be Eligible (Plain English)

Who May Qualify: - Age at disease onset \< 40 years. (Development of symptoms or findings related to Takayasu arteritis at age \<40 years) - Claudication of extremities. (Development and worsening of fatigue and discomfort in muscles of 1 or more extremity while in use, especially the upper extremities) - Decreased brachial artery pulse. (Decreased pulsation of 1 or both brachial arteries) - BP difference \>10 mm Hg. (Difference of \>10 mm Hg in systolic blood pressure between arms) - Bruit audible on auscultation over 1 or both subclavian arteries or abdominal aorta. - Arteriogram abnormality. (Arteriographic narrowing or occlusion of the entire aorta, its primary branches, or large arteries in the proximal upper or lower extremities, not due to arteriosclerosis, fibromuscular dysplasia, or similar causes; changes usually focal or segmental) Who Should NOT Join This Trial: - Vessel lesions that could be entirely due to atherosclerosis. - Giant cell arteritis or other infectious forms of large vessel vasculitis. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age at disease onset \< 40 years. (Development of symptoms or findings related to Takayasu arteritis at age \<40 years) * Claudication of extremities. (Development and worsening of fatigue and discomfort in muscles of 1 or more extremity while in use, especially the upper extremities) * Decreased brachial artery pulse. (Decreased pulsation of 1 or both brachial arteries) * BP difference \>10 mm Hg. (Difference of \>10 mm Hg in systolic blood pressure between arms) * Bruit audible on auscultation over 1 or both subclavian arteries or abdominal aorta. * Arteriogram abnormality. (Arteriographic narrowing or occlusion of the entire aorta, its primary branches, or large arteries in the proximal upper or lower extremities, not due to arteriosclerosis, fibromuscular dysplasia, or similar causes; changes usually focal or segmental) Exclusion Criteria: * Vessel lesions that could be entirely due to atherosclerosis. * Giant cell arteritis or other infectious forms of large vessel vasculitis.

Locations (1)

Fuwai Hospital
Beijing, Beijing Municipality, China